Top compounds associated with response to RASSF3


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.12 0.05
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.074 0.05
mRNA canertinib CTRPv2 pan-cancer AAC -0.079 0.05
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.05
mRNA 5-FU CTRPv2 pan-cancer AAC -0.073 0.05
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.11 0.05
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.074 0.06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.06
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.16 0.06
mRNA Topotecan CCLE pan-cancer AAC -0.087 0.06
Download CSV